
CAS Number65715-12-0
SynonymsView more; Name: Fluorescence polarization based primary biochemical high throughput screening assay o...; Source: 1102; Target: NS3 [Hepatitis C virus]; External Id: 20130523FPNS3DALOPAC; Name: Increase the activity of the Burkholderia fixLJ 2-component system; Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School; Target: Burkholderia multivorans; External Id: HMS1625; Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress; Target: HCMV UL50; External Id: HMS1262; Name: Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection; Target: ORF 73 [Human herpesvirus 8 type M]; External Id: HMS791; Name: Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in ...; External Id: 20130620FPNS3INTERFERELOPAC; Name: Sm
Molecular FormulaC16H16N5NaO7S2
Molecular Weight477.5
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 65715-12-0 |
| Catalog No. | 2A-3180560 |
| Chinese Name | 头孢噻肟杂质D(EP) |
| Synonyms | View more; Name: Fluorescence polarization based primary biochemical high throughput screening assay o...; Source: 1102; Target: NS3 [Hepatitis C virus]; External Id: 20130523FPNS3DALOPAC; Name: Increase the activity of the Burkholderia fixLJ 2-component system; Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School; Target: Burkholderia multivorans; External Id: HMS1625; Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress; Target: HCMV UL50; External Id: HMS1262; Name: Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection; Target: ORF 73 [Human herpesvirus 8 type M]; External Id: HMS791; Name: Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in ...; External Id: 20130620FPNS3INTERFERELOPAC; Name: Sm |
| Molecular Formula | C16H16N5NaO7S2 |
| Molecular Weight | 477.5 |
| PubChem ID | 8149237 |
| InChI | InChI=1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9+;/t10-,14-;/m1./s1 |
| InChI Key | AZZMGZXNTDTSME-AAUIGXPGSA-M |
| Related Products in Analytical Standards | ||
|---|---|---|
| Cefuroxime Sodium EP Impurity C | 69822-88-4 | 2A-3180552 |
| CefuroxiMe Axetil iMpurity C | 76598-06-6 | 2A-3180553 |
| Cefuroxime Sodium EP Impurity F | 97170-19-9 | 2A-3180555 |
| Cefuroxime Sodium EP Impurity G | 97232-98-9 | 2A-3180556 |
| Cefuroxime Impurity 33 | 929531-94-2 | 2A-3180558 |
| Cefathiamidine impurity 12/(6R,7R)-7-(2-bromoacetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 58197-02-7 | 2A-3180566 |
| Cefmetazole impurity | 56796-19-1 | 2A-3180573 |
| Cefmetazole Impurity 4 | 68576-47-6 | 2A-3180574 |
| Cefmetazole sodium Impurity 20 | 70953-18-3 | 2A-3180575 |
| Cefmetazole impurity 9/(6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-3-(hydroxymethyl)-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | 70953-19-4 | 2A-3180576 |
| Browse all Analytical Standards products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA